Company Overview
Turning Glycochemistry into Drug dicovery
Medicinal Chemistry Pharmaceuticals Co., Ltd. (MCP), established 2010 in Sapporo Japan, provides disease-specific formula of glycopeptides as high-quality seed compound library in drug discovery, supporting the creation of antibodies for cancer immunotherapy and the treatment of inflammatory diseases. The seed library is rationally designed with MCP's accumulated knowledge of glycomedicinal chemistry and are synthesized using our specialized glycotechnology. MCP proposes menus of contract/collaboration reserch with the seed library and QuaDRADâ„¢, MCP's antibody drug discovery engine, to create next generation antibody drugs.
Interests